PTEN and gastric cancer: When AKT was inhibited using the PI3K inhibitor, LY-294002, was able to abrogate miR-21-induced cell survival, which suggests that miR-21 may provide a novel mechanism for understanding resistance to CDDP in GC involving the PI3K/PTEN/AKT pathway [47].